524372 Stock Overview
Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Orchid Pharma Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,062.70 |
| 52 Week High | ₹1,358.80 |
| 52 Week Low | ₹385.05 |
| Beta | 2.42 |
| 1 Month Change | 0.52% |
| 3 Month Change | 49.07% |
| 1 Year Change | 169.04% |
| 3 Year Change | -37.40% |
| 5 Year Change | n/a |
| Change since IPO | 5,803.89% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524372 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -2.9% | -0.5% | 1.4% |
| 1Y | 169.0% | 55.3% | 46.1% |
Return vs Industry: 524372 exceeded the Indian Pharmaceuticals industry which returned 55.3% over the past year.
Return vs Market: 524372 exceeded the Indian Market which returned 46.1% over the past year.
Price Volatility
| 524372 volatility | |
|---|---|
| 524372 Average Weekly Movement | 9.7% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 524372's share price has been volatile over the past 3 months.
Volatility Over Time: 524372's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 838 | Manish Dhanuka | www.orchidpharma.com |
Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins, veterinary products, and non-antibiotics. The company’s multi-therapeutic presence in anti-infectives, anti-inflammatory, central nervous system, cardiovascular segment, nutraceuticals, and other oral and sterile products, as well as offers new drug discovery systems and pharmaceutical research and development services.
Orchid Pharma Limited Fundamentals Summary
| 524372 fundamental statistics | |
|---|---|
| Market cap | ₹53.56b |
| Earnings (TTM) | ₹1.25b |
| Revenue (TTM) | ₹8.12b |
43.4x
P/E Ratio6.7x
P/S RatioIs 524372 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524372 income statement (TTM) | |
|---|---|
| Revenue | ₹8.12b |
| Cost of Revenue | ₹4.92b |
| Gross Profit | ₹3.20b |
| Other Expenses | ₹1.96b |
| Earnings | ₹1.25b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 24.56 |
| Gross Margin | 39.44% |
| Net Profit Margin | 15.34% |
| Debt/Equity Ratio | 13.3% |
How did 524372 perform over the long term?
See historical performance and comparison